₨ 8,500
Coageight Injection 500IU is a medication containing the active substance efmoroctocog alfa, which is a recombinant coagulation factor VIII, Fc fusion protein. It is used for the treatment and prevention of bleeding in patients with hemophilia A, an inherited bleeding disorder caused by a deficiency of factor VIII.
Key Information:
- Active Substance: Efmoroctocog alfa.
- Purpose: To replace the missing or deficient factor VIII in patients with hemophilia A.
- Medical Use: It is used for on-demand treatment of bleeding episodes, routine prophylaxis to reduce the frequency of bleeding, and perioperative management of bleeding in patients undergoing surgery.
- Manufacturer: The product is manufactured by ARNOGEN (also referred to as AryoGen Pharmed Co.).
- Dosage: The product shown is 500 IU, which is available in a powder and solvent for solution for injection.
The medication is bioequivalent to Elocta, another recombinant coagulation factor, and has a longer half-life compared to traditional factor VIII products, which can lead to less frequent dosing.Disclaimer: This information is for informational purposes only and is not a substitute for professional medical advice. A healthcare professional should be consulted before taking any medication
₨ 10,000
